Developing multipurpose reproductive health technologies: An integrated strategy

AIDS Research and Treatment

Volumn 2013, Issue , 2013, Pages

  Harrison, P F ^a,b   Hemmerling, A ^a,c   Romano, J ^d   Whaley, K J ^e   Young Holt, B ^a  

^a Public Health Institute ^*  (United States)

^b Global Advocacy for HIV Prevention   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NWJ Group LLC   (United States)

^e Mapp Biopharmaceutical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875416874     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2013/790154     Document Type: Review

References (68)

1. Darroch J. E., Singh S., Estimating Unintended Pregnancies Averted by Couple-Years of Protection (CYP) 2011 New York, NY, USA Guttmacher Institute
2. Singh S., Darroch J. E., Adding It Up: The Costs and Benefits of Investing in Family Planning and Maternal and Newborn Health. Guttmacher Institute and United Nations Population Fund (UNFPA). 2009, http://www. guttmacher.org/pubs/AIU-2012-estimates.pdf
3. World Health Organization, Sexually transmitted infections: Fact Sheet No. 110. 2011, http://www.who.int/mediacentre/factsheets/fs110/en/
4. Looker K. J., Garnett G. P., Schmid G. P., An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bulletin of the World Health Organization 2008 86 10 805 812 2-s2.0-54249103516 10.2471/BLT.07.046128
5. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), Human Papillomavirus and Related Cancers in World. Summary Report 2010. 2010, http://hpv2010.org/main/images/stories/docs/HPVInformationCentre- SummaryReportWorld-Feb2010.pdf
6. Fleming D. T., Wasserheit J. N., From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sexually Transmitted Infections 1999 75 1 3 17 2-s2.0-0033017798 (Pubitemid 29117474)
7. Cohen, MS, Classical sexually transmitted diseases drive the spread of HIV-1: back to the future. The Journal of Infectious Diseases 2012 206 1 1 2
8. Stover J., Dougherty L., Hamilton M., Are Cost Savings Incurred by Offering Family Planning at Emergency Plan HIV/AIDS Care and Treatment Facilities? Futures Group/POLICY Project, Washington, DC, USA, 2006, http://www.policyproject.com/pubs/generalreport/FP- HIV%20Integration%20Costs%20and%20Savings%20Final.pdf
9. Tong A., Sainsbury P., Craig J., Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care 2007 19 6 349 357 2-s2.0-36549063576 10.1093/intqhc/mzm042 (Pubitemid 350186969)
10. Population Council, Facilitating Regulatory Approval of Multipurpose Prevention Technologies (MPTs) for Reproductive Health Day of Dialogue on Multipurpose Prevention Technologies: Toward Clarity in Nomenclature. 2011, http://cami-health.org/documents/2011DayOfDialogueNomenclature-Report.pdf
11. Coalition Advancing Multipurpose Innovations (CAMI), Multipurpose Prevention Technologies for Reproductive Health: Advancing the Scientific and Product Development Agenda Report of a "Think Tank" 2011, http://www.cami-health.org/documents/050511-MPT-ThinkTank.pdf
12. Coalition Advancing Multipurpose Innovations (CAMI), Multipurpose Prevention Technologies for Reproductive Health 2011 Symposium. 2011, http://cami-health.org/documents/MPT2011-Symposium-Report.pdf
13. Coalition Advancing Multipurpose Innovations (CAMI), Global Forum on Multipurpose Prevention Technologies for Reproductive Health. 2011, http://cami-health.org/documents/2012-Global-Forum-Report.pdf
14. Rawe K., Dunford A., Stewart J., Espey J., Stoeckel J., Every Woman's Right. London: Save the Children UK. 2012, http://www.savethechildren.org/atf/ cf/%7B9def2ebe-10ae-432c-9bd0-df91d2eba74a%7D/EVERY-WOMANS-RIGHT-REPORT-JUNE- 2012.PDF
15. Population Reference Bureau, World Population Data Sheet. 2011, http://www.prb.org/pdf11/2011population-data-sheet-eng.pdf
16. Guttmacher Institute and International Planned Parenthood Federation, Facts on Satisfying the Need for Contraception in Developing Countries. November 2010, http://www.imea.fr/imea-fournier/imea-fournier-2010/101122-c- Contraception-PVD.pdf
17. ORC Macro, Demographic and Health Surveys 2004-1010. Calverton, Md, USA, 2013, http://www.measuredhs.com
18. UNFPA, Contraceptive Commodities for Women's Health. Report for UN Commission on Lifesaving commodities for Women and Children. 2012, http://www.unfpa.org/webdav/site/global/shared/images/publications/2012/ UN%20Commission-%20FP%20Synthesis-%20Final%2019%20March%202012.pdf
19. Schwartz S. R., Rees H., Mehta S., Venter W. D., Taha T. E., Black V., High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa. PLoS ONE 2012 7 4 e36039
20. Butler A. R., Smith J. A., Polis C. B., Gregson S., Stanton D., Hallett T. B., Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk. AIDS 2013 27 1 105 113 10.1097/QAD.0b013e32835a5a52
21. Johnson L. F., Dorrington R. E., Bradshaw D., Coetzee D. J., The effect of syndromic management interventions on the prevalence of sexually transmitted infections in South Africa. Sexual and Reproductive Healthcare 2011 2 1 13 20 2-s2.0-78649914901 10.1016/j.srhc.2010.08.006
22. WHO/ICO HPV Information Centre, Human Papillomavirus and Related Cancers in Africa. Summary Report 2010. Table 1: Key statistics in Africa and its regions. 2010
23. Cohen C. R., Lingappa J. R., Baeten J. M., Ngayo M. O., Spiegel C. A., Hong T., Donnell D., Celum C., Kapiga S., Delany S., Bukusi E. A., Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Medicine 2012 9 6 e1001251 10-1371/journal.pmed.1001251
24. Myer L., Denny L., Telerant R., De Souza M., Wright T. C., Kuhn L., Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. Journal of Infectious Diseases 2005 192 8 1372 1380 2-s2.0-25844471659 10.1086/462427 (Pubitemid 41401150)
25. Thoma M. E., Gray R. H., Kiwanuka N., Wang M. C., Sewankambo N., Wawer M. J., The natural history of bacterial vaginosis diagnosed by gram stain among women in Rakai, Uganda. Sexually Transmitted Diseases 2011 38 11 1040 1045
26. Heffron R., Donnell D., Rees H., Celum C., Mugo N., Were E., de Bruyn G., Nakku-Joloba E., Ngure K., Kiarie J., Coombs R. W., Baeten J. M., Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. The Lancet Infectious Diseases 2012 12 1 19 26
27. Office of Registrar General India, Maternal & Child Mortality and Total Fertility Rates Sample Registration System (SRS). 2011, http://censusindia.gov.in/vital-statistics/SRS-Bulletins/MMR-release-070711.pdf
28. Koenig M. A., Acharya R., Roy T. K., Singh S., The Measurement of Unintended Pregnancy in Rural India: A Comparison of Prospective versus Retrospective Assessment. Bloomberg School of Public Health, The Johns Hopkins University (USA) and International Institute for Population Sciences, Mumbai (India). Abstract at PAA 2005, http://paa2005.princeton.edu/download.aspx? submissionId=51322
29. International Institute for Population Sciences (IIPS) and Macro International, National Family Health Survey (NFHS-3), 2005-06: India: Volume I. Mumbai: IIPS, 2007, http://www.measuredhs.com/pubs/pdf/FRIND3/FRIND3- Vol1AndVol2.pdf
30. Santhya K. G., Acharya R., Jejeebhoy S. J., Ram U., Timing of first sex before marriage and its correlates: evidence from India. Culture, Health and Sexuality 2011 13 3 327 341 2-s2.0-79251643513 10.1080/13691058.2010.534819
31. International Institute for Population Sciences (IIPS), District Level Household and Facility Survey (DLHS-3), 2007-08: India. Mumbai: IIPS, 2010, http://www.rchiips.org/pdf/INDIA-REPORT-DLHS-3.pdf
32. AVERT, India HIV & AIDS Statistics. 2013, http://www.avert.org/india- hiv-aids-statistics.htm
33. National Aids Control Organisation (NACO). Ministry Of Health and Family Welfare. Government of India, HIV Sentinel Surveillance and HIV Estimation in India 2007. A Technical Brief. 2008, http://nacoonline.org/upload/Publication/ M&E%20Surveillance,%20Research/ HIV%20Sentinel%20Surveillance%20and%20HIV%20Estimation%202007- A%20Technical%20Brief.pdf
34. National Aids Control Organisation (NACO). Ministry Of Health and Family Welfare. Government of India, National Aids Control Programme III. Report on Mid-Term Review of Sexually Transmitted Infection Services. 2009, http://nacoonline.org/upload/STI%20RTI%20services/STI%20RTI%20MONOGRAPH%20-NACP- III-.pdf
35. Will R., Contraceptive Use in China. US-China Today. University of Southern California US-China Institute. 2012, http://www.uschina.usc.edu/w-usci/ showarticle.aspx?articleID=18021&AspxAutoDetectCookieSupport=1
36. Ministry of Health of the People's Republic of China, 2012 China AIDS Response Progress Report. 2012, http://www.unaids.org/en/dataanalysis/ monitoringcountryprogress/progressreports/2012countries/ce-CN-Narrative- Report[1].pdf
37. UNGASS, China 2010 UNGASS Country Progress Report (2008-2009). 2010, http://data.unaids.org/pub/Report/2010/china-2010-country-progress-report-en.pdf
38. Qian X., Tang S., Garner P., Unintended pregnancy and induced abortion among unmarried women in China: a systematic review. BMC Health Services Research 2004 4, article 1 1 4 2-s2.0-2942511347 10.1186/1472-6963-4-1
39. Fang X., Zhou Y., Yang Y., Diao Y., Li H., Prevalence and risk factors of trichomoniasis, bacterial vaginosis, and candidiasis for married women of child-bearing age in rural Shandong. Japanese Journal of Infectious Diseases 2007 60 5 257 261 2-s2.0-34948886257 (Pubitemid 47516869)
40. Li C., Han H. R., Lee J. E., Lee M., Lee Y., Kim M. T., Knowledge, behaviors and prevalence of reproductive tract infections: a descriptive study on rural women in Hunchun, China. Asian Nursing Research 2010 4 3 122 129 2-s2.0-77957837925 10.1016/S1976-1317(10)60012-6
41. Zhang X. J., Shen Q., Wang G. Y., Yu Y. L., Sun Y. H., Yu G. B., Zhao D., Ye D. Q., Risk factors for reproductive tract infections among married women in rural areas of Anhui Province, China. European Journal of Obstetrics Gynecology and Reproductive Biology 2009 147 2 187 191 2-s2.0-71849119973 10.1016/j.ejogrb.2009.08.017
42. Finer L. B., Kost K., Unintended Pregnancy Rates at the State Level. Perspectives on Sexual and Reproductive Health 2011 43 2 78 87 2-s2.0-79958706007 10.1363/4307811
43. Kost K., Henshaw S., Carlin L., U.S. Teenage Pregnancies, Births and Abortions: National and State Trends and Trends by Race and Ethnicity. 2010, Guttmacher Institute, http://www.guttmacher.org/pubs/USTPtrends.pdf
44. Jones R. K., Kavanaugh M. L., Changes in abortion rates between 2000 and 2008 and lifetime incidence of abortion. Obstetrics & Gynecology 2011 117 6 1358 1366 2-s2.0-79958091546 10.1097/AOG.0b013e31821c405e
45. Finer L. B., Zolna M. R., Unintended pregnancy in the United States: incidence and disparities. Contraception 2006 85 5 478 485
46. Kost K., Henshaw S., U.S. Teenage Pregnancy, Births, and Abortions, 2008: National Trends by Age, Race, and Ethnicity. Guttmacher Institute, February 2012
47. Centers for Disease Control and Prevention, Chlamydia screening among sexually active young female enrollees of health plans-United States, 2000-2007. Morbidity and Mortality Weekly Report 2009 58 14 362 365
48. Centers for Disease Control and Prevention, Genital herpes. CDC Fact Sheet. December 2007, http://www.cdc.gov/std/Herpes/STDFact-Herpes.htm
49. Centers for Disease Control and Prevention, Trichomoniasis, CDC Fact Sheet. December 2007, http://www.cdc.gov/std/trichomonas/STDFact-Trichomoniasis. htm
50. Centers for Disease Control and Prevention, Genital HPV infection. CDC Fact Sheet. May 2004, http://www.cdc.gov/std/HPV/STDFact-HPV.htm
51. Centers for Disease Control and Prevention, HIV in the United States: At A Glance. 2012 http://www.cdc.gov/hiv/resources/factsheets/PDF/HIV-at-a-glance. pdf
52. Centers for Disease Control and Prevention, Morbidity and Mortality Weekly Report 2011 60 31
53. Centers for Disease Control and Prevention, HIV/AIDS in the United States, CDC HIV/AIDS Facts. 2008, http://www.cdc.gov/hiv/resources/factsheets/ us.htm
54. European Centre for Disease Prevention and Control, Sexually Transmitted Infections in Europe, 1990-2009. Stockholm: ECDC, 2011
55. European Centre for Disease Prevention and Control/WHO Regional Office for Europe, HIV/AIDS surveillance in Europe 2010. Stockholm: ECDC, 2011
56. Tebbey P. W., Rink C., Target product profile: a renaissance for its definition and use. Journal of Medical Marketing 2009 9 4 301 307 2-s2.0-75149168562 10.1057/jmm.2009.34
57. Stone A., Advancing Prevention Technologies for Sexual and Reproductive Health. Report of a 2009 Symposium in Berkeley, Calif, USA, http://cami-health. org/resources/reports.php
58. US Food and Drug Administration (USFDA), Center for Drug Evaluation and Research, Guidance for Industry and Review Staff: Target Product Profile-A Strategic Development Process Tool. Draft Guidance, March 2007, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm080593.pdf
59. The Collaboration for AIDS Vaccine Discovery, Topic 4 Overview: Passive Immunization with Human Monoclonal Antibodies for HIV Prevention. Diversifying the Pipeline of Product Concepts for an HIV Vaccine: RFP Overview and Guidelines. Bill & Melinda Gates Foundation, 2010
60. Balazs A. B., Chen J., Hong C. M., Rao D. S., Yang L., Baltimore D., Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature 2011 481 7379 81 84
61. Abdel-Motal U. M., Sarkis P. T. N., Han T., Pudney J., Anderson D. J., Zhu Q., Marasco W. A., Anti-gp120 minibody gene transfer to female genital epithelial cells protects against HIV-1 virus challenge in vitro. PLoS ONE 2011 6 10 e26473
62. Mestecky J., Raska M., Novak J., Alexander R. C., Moldoveanu Z., Antibody-mediated protection and the mucosal immune system of the genital tract: relevance to vaccine design. Journal of Reproductive Immunology 2010 85 1 81 85 2-s2.0-77952423868 10.1016/j.jri.2010.02.003
63. Friend D. R., Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission. Expert Opinion on Drug Delivery 2012 4 9 417 427 10.1517/17425247.2012.668183
64. CONRAD, Online information on current research efforts regarding MPTs. 2013, http://www.conrad.org/research-technologies.html
65. Kenney J., Singer R., Derby N., Aravantinou M., Abraham C. J., Menon R., Seidor S., Zhang S., Gettie A., Blanchard J., Piatak M. Jr., Lifson J. D., Fernández-Romero J. A., Zydowsky T. M., Robbiani M., A single dose of a MIV-150/Zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel use. AIDS Research and Human Retroviruses 2012 28 11 1476 1484 10.1089/AID.2012.0087
66. International Partnership for Microbicides, A microbicide ring to protect against HIV. http://www.dfid.gov.uk/r4d/PDF/Outputs/Microbicides/RING- BACKGROUNDER-%20ENGLISH.pdf
67. Population Council, Critical issues for integrating SRH and HIV/AIDS services to provide dual protection against unintended pregnancy and HIV/STI acquisition. http://www.popcouncil.org/pdfs/events/2012ICCR-Brache.pdf, http://www.popcouncil.org/pdfs/2012RH-STEPUPSymposiumReport.pdf
68. Romano J., High-impact products: necessary attributes, development prospects, and challenges. Presentation at Symposium 6: Prevention of Multiple Reproductive Health Indications, Microbicides 2012 Conference April 2012 Sydney, Australia. http://cami-health.org/convenings/Microbicides-2012.php